SIK3 and cancer: In addition, Charoenfupraset et al. (184) reported SIK3 as a novel TAA as it is involved in the regulation of LKB1’s effects in that increasing expression of SIK3 in OVCAR3 human cancer cells promoted G1/S cell cycle transition and cell growth.